Stockscreener 앱 받기
10.06
0.10%
0.010
시간 외 거래:
10.07
0.010
+0.10%
전일 마감가:
$10.05
열려 있는:
$10.07
하루 거래량:
63,210
Relative Volume:
0.71
시가총액:
$500.99M
수익:
-
순이익/손실:
-
주가수익비율:
1,058.95
EPS:
0.0095
순현금흐름:
-
1주 성능:
+0.60%
1개월 성능:
+0.15%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$10.05
$10.09
1주일 범위
$9.99
$10.09
52주 변동 폭
$9.675
$10.25
New America Acquisition I Corp Stock (NWAX) Company Profile
명칭
New America Acquisition I Corp
전화
212-970-5150
주소
590 MADISON AVENUE, NEW YORK
Compare NWAX vs LION, XXI, UMAC, DMII, BCSS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NWAX
New America Acquisition I Corp
|
10.06 | 500.99M | 0 | 0 | 0 | 0.0095 |
LION
Lionsgate Studios Corp
|
12.45 | 3.61B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
8.02 | 2.78B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
14.09 | 673.32M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.01 | 637.32M | 0 | 4.19M | 0 | 0.065 |
BCSS
Bain Capital Gss Investment Corp
|
10.17 | 593.93M | 0 | 0 | 0 | 0.0729 |
New America Acquisition I Corp 주식(NWAX)의 최신 뉴스
New America Acquisition I Corp. (NWAX-UN) - Minichart
NWAX News | NEW AMERICA ACQUISITION-CL A (NYSE:NWAX) - ChartMill
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Abony Acquisition Corp. I: Performance & Quotes, AACO Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest - MarketBeat
TRG Latin America Acquisitions Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing April 20, 2026 - The Manila Times
TRG Latin America IPO units split into shares and rights Apr. 20 - Stock Titan
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
200,000 NWAX shares bought via entity tied to New America (NWAX) director - Stock Titan
Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal
Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com UK
Proem Acquisition Corp I: Performance & Quotes, PAAC Stock Price on Nasdaq Exchange - marketscreener.com
Idea Acquisition Corp.: Performance & Quotes, IACO Stock Price on Nasdaq Exchange - marketscreener.com
New America Acquisition I Corp. Stock Forecast Summary - Meyka
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement By Investing.com - Investing.com South Africa
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement - Investing.com
$300K zero‑interest note backs Drugs Made In America II (NASDAQ: DMII) - Stock Titan
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Cambridge Acquisition Corp.: Performance & Quotes, CAQ Stock Price on Nasdaq Exchange - marketscreener.com
New America 10-K: $0.0M Revenue; Net income $0.478M (no EPS disclosed) - tradingview.com
New America Acquisition I Corp. Reports Earnings Results for the Seven Months Ended December 31, 2025 - marketscreener.com
New America Acquisition I (NYSE: NWAX) outlines $345M SPAC structure - Stock Titan
Renatus Tactical Acquisition Corp I (RTAC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
FGNA.WS (FG New America Acquisition) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
Drugs Made In America Acquisition Corp. issues $100,000 convertible note as part of $500,000 financing - Investing.com Australia
A&O Shearman guides underwriter on TRG Latin America Acquisitions Corp.’s SPAC IPO - A&O Shearman
TRG Latin America's IPO grows to $206.3M after underwriter buys more units - Stock Titan
Drugs Made in America (DMAA) seeks shareholder vote to extend SPAC deadline - Stock Titan
Complete List of Financial ServicesDiversified Financial ServicesShell Companies Stocks - GuruFocus
14,375,000 Ordinary Shares of Drugs Made In America Acquisition II Corp. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
Stefan Passantino Net Worth (2026) - GuruFocus
Polar Asset Management Partners Inc. Purchases New Position in American Exceptionalism Acquisition Corp. $AEXA - MarketBeat
Drugs Made In America II (NASDAQ: DMII) plans $1.4M convertible note funding - Stock Titan
Dominari Holdings addresses congressional inquiry on Chinese IPOs - Investing.com
Dominari says IPOs are under 10% of revenue as House panel asks on China - Stock Titan
Boothbay Fund Management LLC Sells 70,000 Shares of Drugs Made In America Acquisition Corp. $DMAA - Defense World
Donald Trump Jr. and Eric Trump back drone company Powerus - qz.com
Clear Street Group Inc. Acquires New Holdings in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Boothbay Fund Management LLC Buys New Position in American Exceptionalism Acquisition Corp. $AEXA - MarketBeat
Radcliffe Capital Management L.P. Has $5.42 Million Position in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Trump’s sons back new military drone venture tied to Pentagon work - Moneycontrol.com
Trump sons back launch of new military drone company - Financial Times
$50M KCGI bet, Trump investors behind new U.S. drone merger plan - Stock Titan
Drugs Made In America Acquisition II Corp. confirms trust account balance after review - Investing.com South Africa
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event | DMII SEC FilingForm 8-K - Stock Titan
Drugs Made In America Acquisition Corp. appoints new CEO after board changes - Investing.com Australia
Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue - Investing.com
CEO exits Drugs Made In America (NASDAQ: DMAA) after affiliate fund withdrawals - Stock Titan
Sponsor overpayment leads to CEO change at Drugs Made In America II (DMII) - Stock Titan
Context Capital Management LLC Buys Shares of 250,000 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
New America Acquisition I Corp (NWAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.54%
0.05%
자본화:
|
볼륨(24시간):